Cargando…

Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma

SIMPLE SUMMARY: Primary central nervous system lymphomas are rare, but the incidence in the elderly population increases constantly. Consequently, more and more elderly patients are treated with high-dose chemotherapy followed by autologous stem cell transplantation (HDC/ASCT). However, data on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beer, Sina A., Wirths, Stefan, Vogel, Wichard, Tabatabai, Ghazaleh, Ernemann, Ulrike, Merle, David A., Bethge, Wolfgang, Möhle, Robert, Lengerke, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913690/ https://www.ncbi.nlm.nih.gov/pubmed/36765625 http://dx.doi.org/10.3390/cancers15030669

Ejemplares similares

Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy
por: Roerden, Malte, et al.
Publicado: (2021)

Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case report
por: Tabatabai, Ghazaleh, et al.
Publicado: (2008)

PB1849: EARLY SALVAGE THERAPY WITH VENETOCLAX AND 10-DAY DECITABINE IS FEASIBLE AND SAFE IN REFRACTORY AML: RESULTS FROM 11 PATIENTS WITH EARLY INDUCTION FAILURE
por: Borst, Carla, et al.
Publicado: (2023)

ML-12 HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDC-ASCT) FOR THE PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
por: Miyakita, Yasuji, et al.
Publicado: (2022)

High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system
por: Nilius-Eliliwi, Verena, et al.
Publicado: (2022)

High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
por: Nicolaides, Theodore, et al.
Publicado: (2009)

Correction to: Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2021)

Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2020)

Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
por: Akin, Serkan, et al.
Publicado: (2022)

Primary Autologous Stem Cell Transplantation for Unilateral Primary Central Nervous System Lymphoma–Ophthalmic Variant (Primary Vitreoretinal Lymphoma)
por: Lee, Brian, et al.
Publicado: (2023)

Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
por: Wu, H. G., et al.
Publicado: (1999)

R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience
por: Lee, Ji Yun, et al.
Publicado: (2021)

ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging
por: Nuessle, Nils C., et al.
Publicado: (2021)

Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant
por: Moineau-Vallée, Karine, et al.
Publicado: (2020)

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma
por: Partanen, Anu, et al.
Publicado: (2021)

Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Young Children with Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
por: Park, Eun Sil, et al.
Publicado: (2012)

Efficacy of Procarbazine, Lomustine, and Vincristine Chemotherapy for Recurrent Primary Central Nervous System Lymphomas
por: Kim, Young-Joo, et al.
Publicado: (2015)

Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen
por: Young, Patricia A., et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma
por: Dong, Yan-Hong, et al.
Publicado: (2016)

Primary central nervous system lymphoma
por: Gloghini, Annunziata, et al.
Publicado: (2015)

Primary central nervous system lymphoma
por: Löw, Sarah, et al.
Publicado: (2018)

Rare central nervous system lymphomas
por: Kaji, Furqaan Ahmed, et al.
Publicado: (2022)

Diagnosis and Treatment Using Autologous Stem-Cell Transplantation in Primary Central Nervous System Lymphoma: A Systematic Review
por: Steffanoni, Sara, et al.
Publicado: (2023)

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes
por: Richter, Vivien, et al.
Publicado: (2021)

Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging
por: Hempel, Johann-Martin, et al.
Publicado: (2021)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

ML-04 The influence of surgical intervention for high-dose Methotrexate chemotherapy in the patients with primary central nervous system lymphoma
por: Okamoto, Michinari, et al.
Publicado: (2020)

Research on the Damage of the Central Nervous System Lymphoma to the Nervous System
por: Hernandez, Jairo, et al.
Publicado: (2023)

Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support
por: Pennese, Elsa, et al.
Publicado: (2011)

Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma: A case report
por: Yagi, Yu, et al.
Publicado: (2021)

Sequential CD19/22 CAR T-cell immunotherapy following autologous stem cell transplantation for central nervous system lymphoma
por: Wu, Jiaying, et al.
Publicado: (2021)

Factors Influencing the Response to High Dose Methotrexate-based Vincristine and Procarbazine Combination Chemotherapy for Primary Central Nervous System Lymphoma
por: Sung, Kang Hyun, et al.
Publicado: (2011)

Primary intercavernous lymphoma of the central nervous system
por: Dultra, Arthur Henrique de Aquino, et al.
Publicado: (2015)

Central Nervous System Lymphoma Masquerading as Neurosarcoidosis
por: Arakawa, Akira, et al.
Publicado: (2020)

Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021)

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
por: Ungur, Rodica, et al.
Publicado: (2015)

Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
por: Sun, Xuefei, et al.
Publicado: (2017)

Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis
por: Ollila, Thomas A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hrumt1d1u5sbugocdb1q74ri2k